Search | Clinical Trials Finder

These results were retrieved from the live ClinicalTrials.gov registry. Filters and sort order apply to this result list.

ClinicalTrials.gov public records Last synced Nov 7, 2026, 2:47 PM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Showing 409–432 of 16,401 matching trials from the live ClinicalTrials.gov search.

Filters: Condition: Central Nervous System Disorder Clear all

Conditions: Parkinson Disease
Interventions: B-CIT and SPECT imaging; Drug
Lead sponsor: Institute for Neurodegenerative Disorders; Other
Eligibility: 30 Years and older
Enrollment: 396 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2006 – 2014
U.S. locations: 1
States / cities: New Haven, Connecticut

Conditions: Brain Injury, Ischemic Stroke, Hemorrhagic Stroke
Interventions: Not listed
Lead sponsor: Duke University; Other
Eligibility: 18 Years and older
Enrollment: 34 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2007 – 2008
U.S. locations: 1
States / cities: Durham, North Carolina

Conditions: Tetraplegia
Interventions: Neural Prosthetic System; Device
Lead sponsor: Richard A. Andersen, PhD; Other
Eligibility: 18 Years to 65 Years
Enrollment: 1 participant
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2013 – 2019
U.S. locations: 3
States / cities: Downey, California • Los Angeles, California • Pasadena, California

Conditions: Alzheimer Disease, Aging, Aged, 80 and Over, Biomarkers, Brain, Case-Control Studies, Cognitive Dysfunction, Neuropsychological Tests
Interventions: none, observational study; Other
Lead sponsor: Vanderbilt University Medical Center; Other
Eligibility: 60 Years and older
Enrollment: 1,000 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2012 – 2027
U.S. locations: 1
States / cities: Nashville, Tennessee

Conditions: Phenylketonuria
Interventions: SYNB1618, SYNB1934; Drug
Lead sponsor: Synlogic; Industry
Eligibility: 18 Years and older
Enrollment: 20 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2020 – 2022
U.S. locations: 11
States / cities: Aurora, Colorado • Boca Raton, Florida • Gainesville, Florida + 7 more

Conditions: Astrocytoma, Glioma
Interventions: 5-Aminolevulinic Acid; Drug
Lead sponsor: Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins; Other
Eligibility: 18 Years and older
Enrollment: 6 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2012 – 2016
U.S. locations: 2
States / cities: Baltimore, Maryland

Conditions: Meningitis, Meningococcal
Interventions: MenABCWY vaccine, Placebo; Combination Product
Lead sponsor: GlaxoSmithKline; Industry
Eligibility: 11 Years to 14 Years
Enrollment: 305 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2021 – 2027
U.S. locations: 24
States / cities: Birmingham, Alabama • Tucson, Arizona • Ventura, California + 19 more

Conditions: Type 2 Diabetes Mellitus
Interventions: Not listed
Lead sponsor: Brigham and Women's Hospital; Other
Eligibility: 40 Years to 85 Years
Enrollment: 48,262 participants
Timeline: 2011 – 2019
U.S. locations: 1
States / cities: Boston, Massachusetts

Conditions: Cerebral Palsy
Interventions: Custom EMG triggered Soterix taVNS stimulation with CIMT therapy in lab, Custom EMG triggered Soterix taVNS stimulation with CIMT therapy in home; Combination Product
Lead sponsor: Medical University of South Carolina; Other
Eligibility: 6 Months to 18 Months
Enrollment: 4 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2023 – 2024
U.S. locations: 1
States / cities: Charleston, South Carolina

Conditions: Parkinson Disease (PD)
Interventions: Guided Cycling, Non-Contact Boxing, Traditional Physical Therapy Program (Standard of Care); Behavioral
Lead sponsor: University of Texas, El Paso; Other
Eligibility: 50 Years and older
Enrollment: 45 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2027
U.S. locations: 2
States / cities: El Paso, Texas

Conditions: Alzheimer's Disease, Mild Cognitive Impairment, Frontotemporal Dementia
Interventions: Not listed
Lead sponsor: Medical College of Wisconsin; Other
Eligibility: 50 Years to 90 Years
Healthy volunteers: Accepts healthy volunteers
Timeline: 2009 – 2016
U.S. locations: 1
States / cities: Milwaukee, Wisconsin

Conditions: Stroke, Ischemic
Interventions: Administration of SSRI escitalopram, Paired Associative stimulation, Administration of Placebo; Drug · Behavioral
Lead sponsor: Burke Medical Research Institute; Other
Eligibility: 18 Years and older
Healthy volunteers: Accepts healthy volunteers
Timeline: 2020 – 2021
U.S. locations: 1
States / cities: White Plains, New York

Conditions: Parkinson Disease, Alzheimer Disease, Mild Cognitive Impairment
Interventions: Not listed
Lead sponsor: Columbia University; Other
Eligibility: 55 Years to 90 Years
Enrollment: 120 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2019 – 2028
U.S. locations: 1
States / cities: New York, New York

Conditions: Alzheimer Disease, Progressive Supranuclear Palsy
Interventions: Not listed
Lead sponsor: KineMed; Industry
Eligibility: 50 Years to 85 Years
Enrollment: 16 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2011 – 2013
U.S. locations: 3
States / cities: Glendale, California • Eatontown, New Jersey • San Antonio, Texas

Conditions: Spinal Cord Injuries, Obesity, Cardiometabolic Syndrome
Interventions: PVA Consumer Guide, WebMD; Behavioral
Lead sponsor: University of Miami; Other
Eligibility: 18 Years to 70 Years
Enrollment: 250 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2024 – 2026
U.S. locations: 3
States / cities: Washington D.C., District of Columbia • Miami, Florida • Dallas, Texas

Conditions: Breast Neoplasms
Interventions: Not listed
Lead sponsor: National Institute of Neurological Disorders and Stroke (NINDS); NIH
Eligibility: Female only
Enrollment: 78 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2003 – 2004
U.S. locations: 1
States / cities: Bethesda, Maryland

Conditions: Stroke, Cerebral Palsy, Healthy
Interventions: Rehab in a Crate System; Device
Lead sponsor: University of Pennsylvania; Other
Eligibility: 18 Years and older
Enrollment: 20 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2015 – 2019
U.S. locations: 1
States / cities: Philadelphia, Pennsylvania

Conditions: Mild Concussion, Brain Concussion, Cerebral Concussion
Interventions: Docosahexaenoic acid, Placebo; Dietary Supplement · Drug
Lead sponsor: East Carolina University; Other
Eligibility: 18 Years to 40 Years
Enrollment: 62 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2013 – 2017
U.S. locations: 1
States / cities: Greenville, North Carolina

Conditions: Brain and Central Nervous System Tumors
Interventions: carmustine, topotecan hydrochloride; Drug
Lead sponsor: Duke University; Other
Eligibility: 18 Years and older
Enrollment: 36 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 1997 – 2004
U.S. locations: 2
States / cities: Durham, North Carolina • Memphis, Tennessee

Conditions: Amyotrophic Lateral Sclerosis, Fasciculation
Interventions: FLX-787-ODT; Drug
Lead sponsor: Flex Pharma, Inc.; Industry
Eligibility: 18 Years and older
Enrollment: 3 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2018
U.S. locations: 1
States / cities: Boston, Massachusetts

Conditions: Traumatic Brain Injury
Interventions: FANCI; Behavioral
Lead sponsor: Wake Forest University Health Sciences; Other
Eligibility: 18 Years to 80 Years
Enrollment: 165 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2008 – 2014
U.S. locations: 1
States / cities: Charlotte, North Carolina

Conditions: Acute Ischaemic Stroke, Transient Ischaemic Attack
Interventions: ticagrelor, Acetylsalicylic acid (ASA); Drug
Lead sponsor: AstraZeneca; Industry
Eligibility: 40 Years to 130 Years
Enrollment: 13,307 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2014 – 2016
U.S. locations: 115
States / cities: Montgomery, Alabama • Phoenix, Arizona • Fayetteville, Arkansas + 112 more

Conditions: Cancer
Interventions: caspofungin acetate, liposomal amphotericin B; Drug
Lead sponsor: Memorial Sloan Kettering Cancer Center; Other
Eligibility: 16 Years and older
Healthy volunteers: Healthy volunteers not accepted
Timeline: Started 2000
U.S. locations: 1
States / cities: New York, New York

Conditions: Non-Small-Cell Lung Cancer
Interventions: Cetuximab; Biological
Lead sponsor: Eli Lilly and Company; Industry
Eligibility: 18 Years and older
Enrollment: 66 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2003 – 2005
U.S. locations: 8
States / cities: Aventura, Florida • Miami Beach, Florida • Chicago, Illinois + 4 more

Search by objective public record fields.

Assessing Imaging as a Tool in Monitoring and Predicting the Progression of Parkinson Disease

Estimating Volume Using LiDCO

Providing Brain Control of Extracorporeal Devices to Patients With Quadriplegia

Vanderbilt Memory and Aging Project

Efficacy and Safety of SYNB1618 and SYNB1934 in Adult Patients With Phenylketonuria

Phase I Study of Orally Administered Aminolevulinic Acid for Resection of Malignant Astrocytomas

Safety, Tolerability, and Immunogenicity of MenABCWY Administered on Different Dosing Schedules in Healthy Adolescents

Prediction of Findings From the Ongoing CAROLINA Trial Using Healthcare Database Analyses

Extending taVNS Paired With Infant CIMT Into a Home-Based Setting

Changes in Movement, Fitness, and Quality of Life in People With Parkinson's Disease After Different Exercise Programs

A Composite MR Neuroimaging Marker for Alzheimer's Disease

Dose-finding Study of Selective Serotonin Reuptake Inhibitors to Enhance Neuroplasticity

Autoimmune Features of Neurodegenerative Disorders

Evaluating Cerebrospinal Fluid Biomarkers in Alzheimer's, Progressive Supranuclear Palsy Subjects, and Controls

Spinal Cord Injury Model Systems (SCIMS) - Education Module

Analysis of Brain Metastasis in Patients With Breast Cancer, With and Without Over-Expression of HER-2

Design of an Affordable Gym for Post Stroke Rehabilitation

High Dose Omega-3 Fatty Acids in the Treatment of Sport Related Concussions

Chemotherapy in Treating Patients With Recurrent Malignant Glioma

Study to Evaluate Safety & Efficacy of FLX-787-ODT to Treat Fasciculations in Tongue and Appendicular Muscle in Adult Subjects With ALS

Acute Neurobehavioral Program for Improving Functional Status After TBI

[SOCRATES -Acute Stroke Or Transient IsChaemic Attack TReated With Aspirin or Ticagrelor and Patient OutcomES]

Caspofungin Acetate Compared With Amphotericin B Liposomal in Treating Patients With Persistent Fever and Neutropenia Following Cancer Treatment

Phase II Study in Patients With Recurrent Non-Small-Cell Lung Cancer